UPDATE 1-Amgen sets one lower list price for its cholesterol drug
Drugmaker Amgen Inc said on
Thursday that starting next year, its official list price for
cholesterol drug Repatha will be the lower price it began
offering last year to patients on Medicare and those paying for
the drug out-of-pocket.
Thursday that starting next year, its official list price for
cholesterol drug Repatha will be the lower price it began
offering last year to patients on Medicare and those paying for
the drug out-of-pocket.
Posted by Reuters
